Geode Capital Management’s Leap Therapeutics LPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$92.7K Buy
312,190
+8,079
+3% +$2.4K ﹤0.01% 4076
2025
Q1
$92.8K Sell
304,111
-27,297
-8% -$8.33K ﹤0.01% 4051
2024
Q4
$953K Buy
331,408
+2,117
+0.6% +$6.09K ﹤0.01% 3400
2024
Q3
$847K Buy
329,291
+50,194
+18% +$129K ﹤0.01% 3412
2024
Q2
$547K Buy
279,097
+76,525
+38% +$150K ﹤0.01% 3540
2024
Q1
$539K Sell
202,572
-1,388
-0.7% -$3.69K ﹤0.01% 3586
2023
Q4
$846K Buy
203,960
+60,283
+42% +$250K ﹤0.01% 3414
2023
Q3
$198K Buy
143,677
+52,543
+58% +$72.5K ﹤0.01% 3985
2023
Q2
$285K Buy
91,134
+29,267
+47% +$91.6K ﹤0.01% 3885
2023
Q1
$210K Hold
61,867
﹤0.01% 4026
2022
Q4
$278K Buy
61,867
+990
+2% +$4.45K ﹤0.01% 3929
2022
Q3
$535K Hold
60,877
﹤0.01% 3691
2022
Q2
$700K Hold
60,877
﹤0.01% 3574
2022
Q1
$1.07M Buy
60,877
+4,329
+8% +$75.7K ﹤0.01% 3592
2021
Q4
$1.83M Buy
56,548
+17,359
+44% +$562K ﹤0.01% 3407
2021
Q3
$1.57M Buy
39,189
+2,457
+7% +$98.5K ﹤0.01% 3467
2021
Q2
$602K Buy
36,732
+1,788
+5% +$29.3K ﹤0.01% 3853
2021
Q1
$663K Buy
34,944
+5,039
+17% +$95.6K ﹤0.01% 3712
2020
Q4
$672K Buy
29,905
+12,989
+77% +$292K ﹤0.01% 3496
2020
Q3
$334K Buy
16,916
+2,265
+15% +$44.7K ﹤0.01% 3562
2020
Q2
$306K Sell
14,651
-287
-2% -$5.99K ﹤0.01% 3534
2020
Q1
$236K Sell
14,938
-1,511
-9% -$23.9K ﹤0.01% 3496
2019
Q4
$184K Hold
16,449
﹤0.01% 3821
2019
Q3
$192K Hold
16,449
﹤0.01% 3784
2019
Q2
$294K Buy
16,449
+5,748
+54% +$103K ﹤0.01% 3660
2019
Q1
$200K Buy
10,701
+6,889
+181% +$129K ﹤0.01% 3745
2018
Q4
$76K Hold
3,812
﹤0.01% 3911
2018
Q3
$296K Buy
3,812
+360
+10% +$28K ﹤0.01% 3629
2018
Q2
$310K Buy
+3,452
New +$310K ﹤0.01% 3587